Physician profile
James A Goss
NPI 1295705549
$1,067.42
in general payments reported to CMS, 2019-2025
24 companies · $426 in 2025
The $426 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $41.28 · 2021: $180 · 2023: $100 · 2024: $197 · 2025: $426.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $662 · Travel and Lodging: $61.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $662.00 |
| Travel and Lodging | $61.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $322.24 | 2025 | Tritanium, Makoplasty, Triathlon |
| Ferring Pharmaceuticals INC. | $91.20 | 2020-2025 | Euflexxa |
| Pacira Therapeutics, INC. | $83.87 | 2019-2021 | |
| Depuy Synthes Sales INC. | $72.17 | 2019-2025 | |
| Linvatec Corporation | $64.65 | 2024 | Biobrace 23mm, Allograft Tissue, Hall Power |
| Paragon 28, INC. | $55.75 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $37.62 | 2024-2025 | |
| Masimo Corporation | $35.66 | 2023 | Set and Rainbow Set, Sedline |
| Fidia Pharma USA INC. | $35.18 | 2023-2024 | Hym/Hyn, Hyalgan |
| Sanofi-Aventis U.S. LLC | $28.14 | 2019 | |
| Nalu Medical, INC. | $25.47 | 2024 | Nalu Neurostimulation System |
| Ipsen Biopharmaceuticals, INC | $25.01 | 2024 | Dysport |
| Heron Therapeutics, INC. | $21.29 | 2021 | |
| Daiichi Sankyo INC. | $21.20 | 2021 | |
| Djo, LLC | $17.99 | 2024 | Cmf |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthogenrx INC. | $17.69 | 2019 | |
| Ethicon US, LLC | $15.89 | 2019 | |
| Radius Health, INC. | $15.80 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $15.56 | 2023 | Iovera, Zilretta, Exparel |
| Ossur Americas, INC. | $14.15 | 2024 | Miami J |
| Nevro Corp. | $14.14 | 2024 | Senza |
| Convatec INC. | $12.57 | 2021 | |
| Endo Pharmaceuticals INC. | $12.44 | 2021 | |
| Orthofix Medical, INC. | $11.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Goss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.